Agilent: Back To The Lab - [Business Breakdowns, EP.223]
Show notes
This is Matt Reustle. Today, we are breaking down Agilent. If you aren't familiar with Agilent, it is a $30 billion market cap company at the time of this recording, and they focus on one of the more interesting niches: equipment and instruments sold into laboratories. Its equipment is being sold to the life sciences sector, diagnostics, applied chemical markets, and some very unique R&D work. My guest is Mark de Vos, fund manager at Troy Asset Management, and he brings us through the story of Agilent. It was born within Hewlett-Packard, which spun off a little more than 25 years ago, and Mark helps break down highly complex concepts like chromatography. This is a deeply ingrained industry player with a unique razor and razor blade model and an evolving business. Please enjoy this breakdown of Agilent. For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. —- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes (00:00:00) Welcome to Business Breakdowns (00:02:28) Understanding Agilent's Core Business (00:03:28) Agilent's Market and Customer Base (00:04:55) Agilent's Historical Background (00:08:58) Agilent's Product and Service Strategy (00:13:51) Competition and Market Position (00:24:29) Financial Performance and Growth (00:28:07) New Business Segments and Innovations (00:35:32) Valuation and Investment Insights (00:40:07) Lessons From Agilent
Guests
Analysis: done · source seed